TTF1 and non-small cell lung carcinoma: In terms of response to systemic chemotherapy, several previous studies have also indicated that TTF-1-negative NSCLC exhibits a less favorable therapeutic response with pemetrexed-based chemotherapy than TTF-1-positive NSCLC (7, 15, 16).